MS Society research has shown that damage to myelin can be reversed using stem cells.
The results came from the Cambridge Centre for Myelin Repair and the Edinburgh Centre for Translational Research. The MS Society is hoping that these results will lead to clinical trials in people with MS in the next five years and possible treatment within 15 years.